Literature DB >> 8750084

The spinal loop dialysis catheter: characterization of use in the unanesthetized rat.

M Marsala1, A B Malmberg, T L Yaksh.   

Abstract

To permit long-term measurement of time-dependent changes in levels of dialyzable drugs and transmitters in the spinal intrathecal (i.t.) space of the unanesthetized rat, we developed a dialysis catheter for chronic placement. This was accomplished by constructing a loop probe 9 cm in length from 0.3-mm-diameter dialysis tubing that was made impermeable except for the distal loop. This loop catheter was readily inserted though an incision in the cisternal membrane and passed to the lumbar enlargement. The ends of the catheter were then externalized on the top of the head. To permit i.t. injections, an additional i.t. catheter could also be inserted simultaneously by the same route. For dialysis, an external end of the loop catheter was connected to a syringe pump and perfused with artificial CSF (10 microliters/min) and the out flow collected. A series of studies were performed to demonstrate the characteristics and utility of this technique. (1) Stability of resting release: glutamate and glucose concentrations in spinal dialysate showed no significant changes from 3 to 10 days after implantation. (2) Spinal cord ischemia: ischemia induced by aortic occlusion or cardiac arrest evoked a time dependent increase in retrieved glutamate. (3) Spinal cord compression caused a time-dependent glutamate, aspartate and PGE2 increase. (4) Noxious afferent stimulation induced by the injection of formalin into the hindpaw resulted in a rapid and transient increase in dialysate glutamate concentration. (5) Direct activation of spinal excitatory amino acids receptors by i.t. injection of kainic acid (1 microgram) evoked a significant increase in aspartate and taurine. (6) Continuous delivery of spinal opiate (alfentanil) via dialysis resulted in a maintained, concentration dependent elevation in the thermal escape latencies in the unanesthetized rat. The loop dialysis catheter provides a robust experimental tool for studying time dependent changes in the concentration of diffusible substances in spinal CSF over an extended post-implantation interval and allows comparison of these changes with concurrently assessed behavioral indices.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750084     DOI: 10.1016/0165-0270(95)00053-4

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  18 in total

1.  Modulation of formalin-evoked hyperalgesia by intrathecal N-type Ca channel and protein kinase C inhibitor in the rat.

Authors:  O Nakanishi; T Ishikawa; Y Imamura
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

Review 2.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Intrathecal cocaine delivery enables long-access self-administration with binge-like behavior in mice.

Authors:  Masato Nakamura; Shuibo Gao; Hitoshi Okamura; Daiichiro Nakahara
Journal:  Psychopharmacology (Berl)       Date:  2010-09-23       Impact factor: 4.530

4.  Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF.

Authors:  O Saito; C I Svensson; M W Buczynski; K Wegner; X-Y Hua; S Codeluppi; R H Schaloske; R A Deems; E A Dennis; T L Yaksh
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 5.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

Review 6.  The spinal biology in humans and animals of pain states generated by persistent small afferent input.

Authors:  T L Yaksh; X Y Hua; I Kalcheva; N Nozaki-Taguchi; M Marsala
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

7.  In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.

Authors:  D M Dirig; T L Yaksh
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

8.  Nerve growth factor inducer, 4-methyl catechol, potentiates central sensitization associated with acceleration of spinal glutamate release after mustard oil paw injection in rats.

Authors:  T Ishikawa; O Nakanishi; N Funatsu; H Kameyama
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

9.  Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat.

Authors:  Syuichiro Yamamoto; Osamu Nakanishi; Tomohiro Matsui; Noriyuki Shinohara; Hiroyuki Kinoshita; Clinton Lambert; Toshizo Ishikawa
Journal:  Cell Mol Neurobiol       Date:  2003-04       Impact factor: 5.046

10.  Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.

Authors:  Takashi Okura; Masanori Saito; Misato Nakanishi; Noriyuki Komiyama; Aki Fujii; Shizuo Yamada; Ryohei Kimura
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.